CCCC vs JNJ · rev $12.8M vs P/E 17, rev $49.37B
C4 Therapeutics Inc (CCCC) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CCCC revenue for 2026-06-30 was $12.8M. Net income was -$48.8M. CCCC currently screens at market cap $425.7M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CCCC currently screens at market cap $425.7M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CCCC and JNJ stock pages for the full models.
Not investment advice.